Jyothy Labs Q4 Revenue Up 7.7%, PAT Dips 12% on Inflation; Declares ₹3.50 Dividend

Synopsis:- Reporting a divergence between revenue and profit, Jyothy Labs has posted Q4 FY26 revenue growth of 7.7 percent year-on-year to Rs. 717 crore, while PAT declined 12.3 percent to Rs. 67.5 crore as raw material inflation and margin compression in the Dishwashing segment weighed on the full-year print; the board has recommended a final dividend of Rs. 3.50 per share, with the record date set for June 29, 2026.

Shares of a leading FMCG company came into focus after its board, meeting on May 4, 2026, approved audited financial results for the quarter and full year ended March 31, 2026, alongside a final dividend recommendation. The results reveal a business where the top line is holding its ground but input cost inflation is visibly narrowing segment-level returns across most categories.

With a market capitalization of Rs. 9,969.87 crore, the shares of Jyothy Labs Limited were trading at Rs. 271.5 per share, up 2.2 percent from its previous close of Rs.265.64. It is trading at a P/E of 28.53.

For the quarter ended March 31, 2026, revenue from operations came in at Rs. 717 crore, up 7.7 percent from Rs. 666 crore in Q4 FY25. Despite the top-line gain, profit before tax fell to Rs. 95.5 crore from Rs. 111.3 crore in the comparable quarter, a decline of roughly 14 percent. PAT for Q4 closed at Rs. 67.5 crore against Rs. 77 crore a year ago, a contraction of 12.3 percent.

The full-year picture follows the same direction. FY26 revenue from operations grew 3.5 percent to Rs. 2,944 crore (FY25: Rs. 2,844 crore), but annual PAT fell to Rs. 333 crore from Rs. 371 crore in FY25, a decline of about 10.2 percent. EPS for the full year came in at Rs. 9.07 versus Rs. 10.11 in FY25. The cost of materials consumed for the year rose 8.3 percent to Rs. 1,471 crore, outpacing revenue growth by a wide margin, which largely explains the profit compression.

The board recommended a final dividend of Rs. 3.50 per equity share of face value Re. 1 each for FY26, subject to shareholder approval at the 35th Annual General Meeting scheduled for July 14, 2026. The record date is June 29, 2026, with payment on or after July 14. At the last recorded market price of Rs. 213, the dividend translates to a yield of approximately 1.64 percent. The AGM will be held via video conferencing.

Fabric Care remained the company’s most resilient segment. FY26 revenue from Fabric Care grew 8 percent to Rs. 1,346 crore, though segment-level profit before tax and finance costs still declined to Rs. 268 crore from Rs. 295 crore in FY25, a 9 percent drop, pointing to margin pressure even in the company’s best-performing vertical.

Dishwashing, the second-largest segment at Rs. 959 crore in FY26, saw revenue contract marginally versus FY25’s Rs. 972 crore, while segment profit fell sharply from Rs. 183 crore to Rs. 151 crore, a 17.9 percent decline. Household Insecticides improved relative to a weak FY25 base, narrowing its segment loss from Rs. 24.7 crore to Rs. 4.6 crore. Personal Care grew 5.2 percent on revenue but segment profit fell 28 percent to Rs. 25.3 crore from Rs. 35.3 crore, a segment where higher advertising and promotional spend appears to be landing the cost before the revenue benefit fully arrives. Advertisement and sales promotion expense for the full year stood at Rs. 227 crore, broadly flat versus FY25’s Rs. 240 crore, suggesting the margin pressure is cost-of-goods rather than marketing-led.

Business Overview

Jyothy Labs Limited, founded in 1983 and headquartered in Mumbai, manufactures household and personal care products across Fabric Care (Ujala, Henko), Dishwashing (Exo, Pril), Household Insecticides, and Personal Care categories. The company is listed on BSE and NSE and operates on a standalone basis following the divestiture of its Bangladesh subsidiary in March 2025.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Jyothy Labs Q4 Revenue Up 7.7%, PAT Dips 12% on Inflation; Declares ₹3.50 Dividend appeared first on Trade Brains.